MDGL · Madrigal Pharmaceuticals, Inc.
$507.56
+0.19 (+0.04%)
At close · Aug 14
Market Cap
$11.73B
Shares
23.10M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-12 | 2026-08-11 | |
| Investor Event Transcript | 2026-08-11 | 2026-09-30 | |
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-06-17 | 2026-06-16 | |
| Investor Event Transcript | 2026-06-10 | 2026-06-30 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| DEF 14A | 2026-04-28 | 2026-06-17 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-02-19 | 2025-12-31 | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-30 | 2026-01-29 | |
| 8-K | 2025-12-11 | 2025-12-05 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-07-22 | 2025-07-17 | |
| 8-K | 2025-06-20 | — | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-20 | |
| 8-K | 2025-04-17 | 2025-04-16 | |
| 8-K | 2025-03-11 | 2025-03-09 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-27 | 2024-06-25 | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-25 | |
| 8-K | 2024-04-02 | 2024-03-27 | |
| 8-K | 2024-03-20 | 2024-03-18 | |
| 8-K | 2024-03-15 | 2024-03-14 | |
| 8-K | 2024-02-28 | 2024-02-22 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-10-02 | 2023-09-28 | |
| 8-K | 2023-09-25 | 2023-09-20 |
Showing 1–50 of 104 filings
Key facts
CIK
1157601
CUSIP
558868105
13F (30d)
386 filings
383 filers
Visit website
Investor relations